CereCura Nanotherapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

CereCura Nanotherapeutics General Information

Description

Operator of next-generation neurological therapeutics intended to treat brain disease. The company's platform combines lipid nanoparticle (LNP) delivery with RNA technology, enabling targeted, modular, and flexible delivery of nucleic acid payloads to the central nervous system, overcoming the blood-brain barrier and supporting sustained protein production in the brain, enabling the biotech and pharmaceutical market to address unmet needs in neurological disorders.

Contact Information

Website
www.cerecura.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2215 Wesbrook Mall
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, HealthTech, Life Sciences
Corporate Office
  • 2215 Wesbrook Mall
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604)

CereCura Nanotherapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CereCura Nanotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Accelerator/Incubator 22-Sep-2026 Completed Pre-Clinical Trials
9. Seed Round 14-Nov-2025 Completed Pre-Clinical Trials
8. Accelerator/Incubator 24-Jan-2025 Completed Pre-Clinical Trials
7. Accelerator/Incubator 08-Oct-2024 Completed Pre-Clinical Trials
6. Accelerator/Incubator 04-Oct-2024 Completed Pre-Clinical Trials
5. Seed Round Completed Pre-Clinical Trials
4. Grant Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2022 Completed Pre-Clinical Trials
To view CereCura Nanotherapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CereCura Nanotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CereCura Nanotherapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital BioVentures Accelerator/Incubator
eFund (Canada) Angel Group Minority
Hextwo Capital Venture Capital Minority
UBC Seed Fund Venture Capital Minority
WUTIF Capital Angel Group Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

CereCura Nanotherapeutics FAQs

  • When was CereCura Nanotherapeutics founded?

    CereCura Nanotherapeutics was founded in 2022.

  • Where is CereCura Nanotherapeutics headquartered?

    CereCura Nanotherapeutics is headquartered in Vancouver, Canada.

  • What is the size of CereCura Nanotherapeutics?

    CereCura Nanotherapeutics has 10 total employees.

  • What industry is CereCura Nanotherapeutics in?

    CereCura Nanotherapeutics’s primary industry is Drug Discovery.

  • Is CereCura Nanotherapeutics a private or public company?

    CereCura Nanotherapeutics is a Private company.

  • What is CereCura Nanotherapeutics’s current revenue?

    The current revenue for CereCura Nanotherapeutics is .

  • How much funding has CereCura Nanotherapeutics raised over time?

    CereCura Nanotherapeutics has raised $1.8M.

  • Who are CereCura Nanotherapeutics’s investors?

    Capital BioVentures, eFund (Canada), Hextwo Capital, UBC Seed Fund, and WUTIF Capital are 5 of 11 investors who have invested in CereCura Nanotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process